NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan & LONDON--(BUSINESS WIRE)--Gensource Potash Corporation (“Gensource” or the “Company”) (AIM/TSXV: GSP), a fertilizer development company
MHRA Approval follows European Commission marketing authorization of LUPKYNIS to treat adults with active lupus nephritis in 27 European Union Member States LUPKYNIS is the first oral medicine approved in the U.S. and Europe for the treatment of adults
KGK has submitted a clinical trial application for Phase IIa clinical trial to test the efficacy of psilocybin on Fragile X syndrome VANCOUVER, British Columbia--(BUSINESS WIRE)--$KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or t
VICTORIA, British Columbia & VANCOUVER, British Columbia & PHILADELPHIA--(BUSINESS WIRE)--$IPA #AI--IPA (IMMUNOPRECISE ANTIBODIES LTD.) ( “IPA”) (NASDAQ: IPA), an advanced biotherapeutic research and technology company, today announced that BioStrand
Regulatory Affairs and Clinical Operations Vice Presidents Add Key Expertise as Company Prepares to Initiate U.S. Clinical Trials SEATTLE, BOSTON & TOKYO--(BUSINESS WIRE)--Aurion Biotech, whose mission is to restore vision to millions of patients with it
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improveme
Optune is the first treatment for glioblastoma approved in Canada in over 12 years Novocure is actively working to secure reimbursement of Optune to make the therapy accessible for glioblastoma patients ROOT, Switzerland--(BUSINESS WIRE)--$NVCR--Novocur
Clinic reaches patient milestone in less than two years since being acquired by Wellbeing Digital Sciences VANCOUVER, British Columbia--(BUSINESS WIRE)--$KONEF #psychedelics--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: ME
Data from Phase 2 Clinical Trial May Also Provide Insights into Diabetes- and Obesity-related Complications MONTREAL--(BUSINESS WIRE)--Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of peripherally-actin
SAN DIEGO--(BUSINESS WIRE)--#NCI--Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid tumors, today announced that it has entered into a Cooperative Research and Development A
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.